GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts2233
Avg. Estimate-0.13-0.13-0.48-0.69
Low Estimate-0.17-0.18-0.6-0.81
High Estimate-0.09-0.08-0.35-0.53
Year Ago EPS-0.15-0.14-0.49-0.48
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts2233
Avg. EstimateN/AN/A3.33M5M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/A10M15M
Year Ago SalesN/AN/AN/A3.33M
Sales Growth (year/est)N/AN/AN/A50.20%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.16-0.15-0.14-0.11
EPS Actual-0.15-0.14-0.13-0.07
Difference0.010.010.010.04
Surprise %6.30%6.70%7.10%36.40%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.13-0.13-0.48-0.69
7 Days Ago-0.13-0.13-0.48-0.69
30 Days Ago-0.13-0.13-0.48-0.69
60 Days Ago-0.13-0.13-0.48-0.69
90 Days Ago-0.13-0.13-0.48-0.69
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesGALTIndustrySectorS&P 500
Current Qtr.13.30%N/AN/A0.42
Next Qtr.7.10%N/AN/A0.39
Current Year2.00%N/AN/A0.20
Next Year-43.70%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A